164 related articles for article (PubMed ID: 31268734)
21. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
22. MRI-safe robot for targeted transrectal prostate biopsy: animal experiments.
Srimathveeravalli G; Kim C; Petrisor D; Ezell P; Coleman J; Hricak H; Solomon SB; Stoianovici D
BJU Int; 2014 Jun; 113(6):977-85. PubMed ID: 24118992
[TBL] [Abstract][Full Text] [Related]
23. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
24. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
25. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of a 2
Bomers JGR; Bosboom DGH; Tigelaar GH; Sabisch J; Fütterer JJ; Yakar D
Eur Radiol; 2017 Apr; 27(4):1776-1782. PubMed ID: 27436021
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and Characterization.
Porpiglia F; De Luca S; Passera R; De Pascale A; Amparore D; Cattaneo G; Checcucci E; De Cillis S; Garrou D; Manfredi M; Mele F; Bollito E; Fiori C
J Urol; 2017 Jul; 198(1):58-64. PubMed ID: 28093292
[TBL] [Abstract][Full Text] [Related]
28. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
[TBL] [Abstract][Full Text] [Related]
30. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
[TBL] [Abstract][Full Text] [Related]
31. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
32. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
[TBL] [Abstract][Full Text] [Related]
33. In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve.
Friedl A; Schneeweiss J; Sevcenco S; Eredics K; Kunit T; Susani M; Kivaranovic D; Eisenhuber-Stadler E; Lusuardi L; Brössner C; Schima W
Urology; 2018 Apr; 114():139-146. PubMed ID: 29330001
[TBL] [Abstract][Full Text] [Related]
34. Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy.
Zhang M; Milot L; Khalvati F; Sugar L; Downes M; Baig SM; Klotz L; Haider MA
Radiology; 2019 Apr; 291(1):83-89. PubMed ID: 30694165
[TBL] [Abstract][Full Text] [Related]
35. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC
J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918
[TBL] [Abstract][Full Text] [Related]
36. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
37. Comparison between "In-bore" MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results.
D'Agostino D; Mineo Bianchi F; Romagnoli D; Corsi P; Giampaoli M; Schiavina R; Brunocilla E; Artibani W; Porreca A
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266272
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
[TBL] [Abstract][Full Text] [Related]
39. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
40. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]